Philip E.V. Van Kerrebroeck has been Professor of Urology at Maastricht University (Netherlands) since November 1998, and works as a urologist at the Maastricht University Medical Centre. After obtaining his medical degree from the University of Louvain, Belgium, he trained in General Surgery and Urology in Belgium, The Netherlands and the USA.
Van Kerrebroeck has a long-standing clinical interest in different forms of lower urinary tract problems, both in women and men, including neurogenic bladder dysfunction and nocturia. His research interests include the development of new therapies in neuro-urology and functional urology, such as pharmacotherapy and neuromodulation.
Van Kerrebroeck was board member of the International Continence Society and Chairman of their Standardisation Committee for 8 years. He was involved in the New England Research Institutes Interdisciplinary Conferences on Nocturia, was Chairman of the ICI-RS Nocturia Think Tank and was first author of the 2002 ICS Standardisation Document on Nocturia.
Van Kerrebroeck is a member of 25 scientific societies; he serves on the editorial board of 6 journals, and has authored over 316 peer-reviewed articles, book chapters and books. He currently serves as a Board member of the European Association of Urology and is the Chairman of its History Office.
Dr. Sajjad Rahnama’i works as a consultant urologist at the Uniklinik RWTH in Aachen, Germany. He conducted his PhD research in functional urology at Maastricht University in the Netherlands where he still has some research activities as an assistant professor of urology.
Rahnama’i is an active member of the EAU Section of Female and Functional Urology (ESFFU) and the International Continence Society (ICS). For his research activities, Rahnama’i has received several research awards such as the Eugen Rhefisch Medal of the German Forum Urodynamicum and the Professor Moonen price of the Dutch Urological Society. He has published more than 40 articles in peer-reviewed journals. The current research of Dr. Rahnama’i focusses on the association of obstructive sleep apnoea syndrome (OSAS) and nocturia as well as functional brain imaging of patients with bladder function disorders.